"
Improvement of Survival in Patient with Primary Metastatic Breast Cancer over a 10-Year Periode: Prospective Analyses Based on Individual Patient Date from a Multicenter Data Bank"
written by Jana Barinoff, Florian Heitz, Sherko Kuemmel, Christine Dittmer, Rita Hils, Fatemeh Lorenz-Salehi, Alexander Traut, Andreas du Bois,
published by
Journal of Cancer Therapy,
Vol.4 No.8, 2013
has been cited by the following article(s):
[1]
|
Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer
Medicine,
2021
DOI:10.1097/MD.0000000000026619
|
|
|
[2]
|
Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer
Medicine,
2021
DOI:10.1097/MD.0000000000026619
|
|
|
[3]
|
Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer
Medicine,
2021
DOI:10.1097/MD.0000000000026619
|
|
|
[4]
|
Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery
European Journal of Cancer,
2017
DOI:10.1016/j.ejca.2017.06.002
|
|
|
[5]
|
Epidemiology-Based Assessment of Tumor Marker Overordering in Breast Cancer: An Algorithm to Examine Different Disease Conditions
The International Journal of Biological Markers,
2017
DOI:10.5301/ijbm.5000274
|
|
|